PDPK1 and melanoma: As the PDPK1-AKT pathway, in addition to activating the transcription of HIF-1α [31,32], also promotes cell surface expression of GLUT1, inhibition of AKT phosphorylation by ACF might have a major impact on glucose metabolism in melanoma cells.